Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001558370-17-002742
Filing Date
2017-04-20
Accepted
2017-04-20 09:32:24
Documents
3
Period of Report
2017-05-25
Effectiveness Date
2017-04-20

Document Format Files

Seq Description Document Type Size
1 DEF 14A glyc-20170525xdef14a.htm DEF 14A 1184518
2 GRAPHIC glyc20170525xdef14a001.jpg GRAPHIC 7001
3 GRAPHIC glyc20170525xdef14a002.jpg GRAPHIC 959
  Complete submission text file 0001558370-17-002742.txt   1196817
Mailing Address 9708 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9708 MEDICAL CENTER DRIVE ROCKVILLE MD 20850 240-243-1201
GLYCOMIMETICS INC (Filer) CIK: 0001253689 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36177 | Film No.: 17771634
SIC: 2834 Pharmaceutical Preparations